by Admin | Jun 30, 2021 | Portfolio News
MENDHAM, N.J. and WARMINSTER, Pa., – Antios Therapeutics, Inc. and Arbutus Biopharma Corporation (Nasdaq: ABUS) today announced that the companies have entered into a clinical collaboration agreement to evaluate a triple combination of Arbutus’ proprietary GalNAc...
by Admin | Jun 30, 2021 | Portfolio News
Pending WHO EUL for its COVID-19 vaccine candidate, Clover is committed to providing 64 million doses in 2021 and Gavi has options for an additional 350 million doses in 2022Clover will receive a significant upfront payment, a payment upon positive Phase 2/3 data,...
by Admin | May 6, 2021 | Portfolio News
美国圣地亚哥，中国上海、广东松山湖 2021年5月6日，凡恩世生物医药公司（Phanes Therapeutics以下简称“凡恩世”或“公司”）正式宣布完成B轮4千万美元融资。本轮融资由红杉资本中国基金领投，德屹资本、火山石投资、康禧全球投资基金、文周基金跟投，老股东险峰旗云和天使投资人追加投资。生命资本担任本次融资的独家财务顾问。本轮融资将全面加速凡恩世研发管线中多个抗肿瘤单抗及双抗产品的临床转化。...
by Admin | Apr 27, 2021 | Portfolio News
By Antios Therapeutics, Inc. on Tuesday, Apr 27, 2021 Responsible for managing clinical development and the regulatory processes for ATI-2173, an ASPIN, which is in development as part of a potential curative regimen for chronic hepatitis B infection MENDHAM, N.J.,...
by Admin | Apr 22, 2021 | Portfolio News
By Antios Therapeutics, Inc. on Wednesday, Apr 21, 2021 SAVE 1 to evaluate ATI-2173 in combination with tenofovir (TDF) vs. TDF plus placebo SAVE 1 to include cohort of Hepatitis Delta Virus (HDV) co-infected subjects to assess ATI-2173 activity against HDV MENDHAM,...
by Admin | Apr 14, 2021 | Portfolio News
While hepatitis B virus (HBV) infection is avoidable with a vaccine, a host of companies are searching for a cure for the hundreds of thousands in the US who already have it. Antios Therapeutics threw its hat in the ring three years ago, and on Monday...
by Admin | Apr 12, 2021 | Portfolio News
Angus Liu | Apr 12, 2021 7:55am Last year, OncoMyx Therapeutics unveiled preclinical data showing its engineered rabbit pox virus therapy could slow tumor growth in mouse models of melanoma and bone cancer. Now, it’s unveiling more preclinical evidence,...
by Admin | Apr 12, 2021 | Portfolio News
April 12, 2021 07:30 ET | Source: Antios Therapeutics Inc. Funding will support the Phase 2 clinical program of ATI-2173 in HBV Soleus Capital led the round with new major investors RA Capital Management, Adage Capital Management LP, Pontifax and Aisling Capital as...
by Admin | Mar 24, 2021 | Portfolio News
News provided by Clover Biopharmaceuticals Mar 24, 2021, 02:15 ET Over 22,000 participants aged 18 years or older are expected to be enrolled in SPECTRA across Latin America, Asia, Europe and AfricaInterim analysis of the primary endpoint expected in the middle of...
by Admin | Feb 23, 2021 | Portfolio News
•Series C financing brings total capital raised in the last 12 months to over US$ 400 million (>RMB 2.5 billion) •The proceeds will support the continued development and expansion of Clover’s pipeline of protein-based vaccines and biologic cancer therapies CHENGDU,...
